Our study, which evaluated CD4 recovery during 5 years of effective antiretroviral treatment, suggests that clinical biomarkers such as younger age, higher CD4 baseline cell count, higher HIV viral load at the initiation of ART and the introduction of ART at the point of acute HIV infection are positive predictors of immune reconstitution. This evidence concerns the gene CD4 and HIV infectious disease.